Fatal familial insomnia that begins with unconsciousness: A case report

Wenyan Liu , Xinyue Xing , Xiaoming Wang , Xuqian Liu , Mingyue Liu , Wei Shang , Zhaohong Xie

Sleep Research ›› 2026, Vol. 3 ›› Issue (1) : 71 -77.

PDF (1606KB)
Sleep Research ›› 2026, Vol. 3 ›› Issue (1) :71 -77. DOI: 10.1002/slp2.70029
CASE REPORT
Fatal familial insomnia that begins with unconsciousness: A case report
Author information +
History +
PDF (1606KB)

Keywords

case report / fatal familial insomnia / insomnia / prion disease / PRNP gene

Cite this article

Download citation ▾
Wenyan Liu, Xinyue Xing, Xiaoming Wang, Xuqian Liu, Mingyue Liu, Wei Shang, Zhaohong Xie. Fatal familial insomnia that begins with unconsciousness: A case report. Sleep Research, 2026, 3 (1) : 71-77 DOI:10.1002/slp2.70029

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Gambetti P, Parchi P, Petersen RB, Chen SG, Lugaresi E. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features. Brain Pathol. 1995;5(1):43-51. https://doi.org/10.1111/j.1750-3639.1995.tb00576.x

[2]

Schenkein J, Montagna P. Self management of fatal familial insomnia. Part 1: what is FFI? MedGenMed. 2006;8(3):65.

[3]

Baldelli L, Provini F. Fatal familial insomnia and Agrypnia Excitata: autonomic dysfunctions and pathophysiological implications. Auton Neurosci. 2019;218:68-86. https://doi.org/10.1016/j.autneu.2019.02.007

[4]

Montagna P, Gambetti P, Cortelli P, Lugaresi E. Familial and sporadic fatal insomnia. Lancet Neurol. 2003;2(3):167-176. https://doi.org/10.1016/s1474-4422(03)00323-5

[5]

Sforza E, Montagna P, Tinuper P, et al. Sleep-wake cycle abnormalities in fatal familial insomnia. Evidence of the role of the thalamus in sleep regulation. Electroencephalogr Clin Neurophysiol. 1995;94(6):398-405. https://doi.org/10.1016/0013-4694(94)00318-f

[6]

Benarroch EE, Stotz-Potter EH. Dysautonomia in fatal familial insomnia as an indicator of the potential role of the thalamus in autonomic control. Brain Pathol. 1998;8(3):527-530. https://doi.org/10.1111/j.1750-3639.1998.tb00174.x

[7]

Portaluppi F, Cortelli P, Avoni P, et al. Diurnal blood pressure variation and hormonal correlates in fatal familial insomnia. Hypertension. 1994;23(5):569-576. https://doi.org/10.1161/01.hyp.23.5.569

[8]

Hill AF, Joiner S, Wadsworth JDF, et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain. 2003;126(Pt 6):1333-1346. https://doi.org/10.1093/brain/awg125

[9]

Perani D, Cortelli P, Lucignani G, et al. [18F]FDG PET in fatal familial insomnia: the functional effects of thalamic lesions. Neurology. 1993;43(12):2565-2569. https://doi.org/10.1212/wnl.43.12.2565

[10]

Cortelli P, Perani D, Parchi P, et al. Cerebral metabolism in fatal familial insomnia: relation to duration, neuropathology, and distribution of protease-resistant prion protein. Neurology. 1997;49(1):126-133. https://doi.org/10.1212/wnl.49.1.126

[11]

Grau-Rivera O, Calvo A, Bargalló N, et al. Quantitative magnetic resonance abnormalities in Creutzfeldt-Jakob disease and fatal insomnia. J Alzheimers Dis. 2017;55(1):431-443. https://doi.org/10.3233/jad-160750

[12]

Abu-Rumeileh S, Capellari S, Stanzani-Maserati M, et al. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias. Alzheimers Res Ther. 2018;10(1):3. https://doi.org/10.1186/s13195-017-0331-1

[13]

Synofzik M, Bauer P, Schöls L. Prion mutation D178N with highly variable disease onset and phenotype. J Neurol Neurosurg Psychiatry. 2009;80(3):345-346. https://doi.org/10.1136/jnnp.2008.149922

[14]

Zarranz JJ, Digon A, Atarés B, et al. Phenotypic variability in familial prion diseases due to the D178N mutation. J Neurol Neurosurg Psychiatry. 2005;76(11):1491-1496. https://doi.org/10.1136/jnnp.2004.056606

[15]

Gambetti P, Parchi P, Chen SG. Hereditary Creutzfeldt-Jakob disease and fatal familial insomnia. Clin Lab Med. 2003;23(1):43-64. https://doi.org/10.1016/s0272-2712(02)00065-3

[16]

McLean CA, Storey E, Gardner R, Tannenberg AE, Cervenáková L, Brown P. The D178N (cis-129M) “fatal familial insomnia” mutation associated with diverse clinicopathologic phenotypes in an Australian kindred. Neurology. 1997;49(2):552-558. https://doi.org/10.1212/wnl.49.2.552

[17]

Pérez-Carbonell L, Muñoz-Lopetegi A, Sánchez-Valle R, et al. Sleep architecture and sleep-disordered breathing in fatal insomnia. Sleep Med. 2022;100:311-346.

[18]

Casas-Méndez LF, Lujan M, Vigil L, et al. Biot's breathing in a woman with fatal familial insomnia: is there a role for noninvasive ventilation? J Clin Sleep Med. 2011;7(1):89-91.

[19]

Minikel EV, Zhao HT, Le J, et al. Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints. Nucleic Acids Res. 2020;48(19):10615-10631. https://doi.org/10.1093/nar/gkaa616

[20]

Bauer S, Dittrich L, Kaczmarczyk L, Schleif M, Benfeitas R, Jackson WS. Translatome profiling in fatal familial insomnia implicates TOR signaling in somatostatin neurons. Life Sci Alliance. 2022;5(11):e202201530. https://doi.org/10.26508/lsa.202201530

RIGHTS & PERMISSIONS

2026 The Author(s). Sleep Research published by John Wiley & Sons Australia, Ltd on behalf of Chinese Sleep Research Society.

PDF (1606KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/